Therapeutically Targeting Platelet-Derived Growth Factor-Mediated Signaling Underlying the Pathogenesis of Subarachnoid Hemorrhage-Related Vasospasm
- 1 September 2018
- journal article
- review article
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 27 (9) , 2289-2295
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activationJournal of Surgical Research, 2013
- Suppression of the Rho/Rho-Kinase Pathway and Prevention of Cerebral Vasospasm by Combination Treatment with Statin and Fasudil After Subarachnoid Hemorrhage in RabbitTranslational Stroke Research, 2013
- Proteomic Biomarker Discovery in Cerebrospinal Fluid for Cerebral Vasospasm Following Subarachnoid HemorrhageJournal of Stroke and Cerebrovascular Diseases, 2012
- Combined argatroban and anti‐oxidative agents prevents increased vascular contractility to thrombin and other ligands after subarachnoid haemorrhageBritish Journal of Pharmacology, 2011
- Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhageSurgical Neurology, 2009
- Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathyExperimental & Molecular Medicine, 2009
- Role of platelet-derived growth factors in physiology and medicineGenes & Development, 2008
- Rho Kinase (ROCK) InhibitorsJournal of Cardiovascular Pharmacology, 2007
- Rat Brain Capillary Endothelial Cells Express Functional PDGF B-Type ReceptorsGrowth Factors, 1989
- Evaluation of the role hemoglobin in cerebrospinal fluid plays in producing contractions of cerebral arteriesSurgical Neurology, 1987